Condition
Hydrothorax
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06856655Completed
Achieving Portal Access With Scorpion Post-Approval Study 2
NCT06658080Recruiting
Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
NCT05765253Not ApplicableTerminated
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
NCT04143360Not ApplicableUnknownPrimary
Improvement and Application of New Closed Drainage Device
NCT01522885Phase 3Completed
KatGuide Method Versus Conventional Method at Insertion of Chest Tube
Showing all 5 trials